PUBLICATIONS
Hamill Skoch S, Stimpfl J,* Strawn JR. Evidence-based review: treatment of pediatric insomnia. Current Psychiatry 2021 (accepted).
Luft MJ,* Dobson ET, Levine A, Croarkin PE and Strawn JR. Pharmacologic interventions for antidepressant-induced sexual dysfunction: a systematic review and network meta-analysis of trials using the Arizona sexual experiences scale. CNS Spectrums 2021 (in press). PMID: 33843553
Mossman SA*, Mills JA, Walkup JT, Strawn JR. The impact of failed antidepressant trials on outcomes in children and adolescents with anxiety and depression: a systematic review and meta-analysis. Journal of Child & Adolescent Psychopharmacology 2021 (in press). PMID: 33887154.
Hamill Skoch S, Mills JA, Ramsey L, Strawn JR. Sleep disturbances in selective serotonin reuptake inhibitor-treated youth with anxiety disorders and obsessive compulsive disorder- a Bayesian hierarchical modeling meta-analysis. Journal of Child & Adolescent Psychopharmacology 2021 (in press). PMID: 33571033.
Lu L*, Mills JA, Li H, Schroeder HK, Mossman SA, Varney ST, Cecil KM, Huang X, Gong Q, Ramsey LB, DelBello MP, Sweeney JA, Strawn JR. Acute neurofunctional effects of escitalopram in pediatric anxiety: a double-blind, placebo-controlled trial. Journal of the American Academy of Child & Adolescent Psychiatry. 2021 (in press). PMID: 33548492
Nery FG, Welge JA, Fleck D, Weber W, Eliassen JC, Patino LR, Strawn JR, Adler CM, Strakowski SM, DelBello MP. Associations between poor tolerability to antidepressant treatment and brain functional activation in youth at risk for bipolar disorder. Brazilian Journal of Psychiatry 2021 (in press). PMID: 32876131
Ramsey LB, Namerow LB, Bishop JR, Hicks JK, Bousman C, Croarkin PE, Matthews CA, Van Driest SL, Strawn JR. Thoughtful clinical use of pharmacogenetics in child and adolescent psychopharmacology. Journal of the American Academy of Child & Adolescent Psychiatry. 2021 (in press). PMID: 32860906
Walkup JT, Friedland SJ, Peris TS, Strawn JR. Dysregulation, catastrophic reactions, and the anxiety disorders. Child Adolesc Psychiatr Clin N Am. 2021;30(2):431-444. PMID: 33743949.
Strawn JR, Lu L* (co-first author), Peris TS, Levine A, Walkup JT. Research review: pediatric anxiety disorders: what have we learnt in the last 10 years? Journal of Child Psychology & Psychiatry. 2021;62(2):114-139. PMID: 32500537.
Croarkin PE, Elmaadawi AZ, Aaronson ST, Schrodt GR Jr, Holbert RC, Verdoliva S, Heart KL, Demitrack MA, Strawn JR. Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial. Neuropsychopharmacology. 2021;46(2):462-469. PMID: 32919400
Dobson ET*, Croarkin PE, Schroeder HK, Varney ST, Mossman SA, Cecil K, Strawn JR. Bridging anxiety and depression: a network approach in anxious adolescents. Journal of Affective Disorders. 2021;280:305-314. PMID: 33221716
Lu L, Li H, Mills JA, Schroeder H, Mossman SA, Varney ST, Cecil KM, Huang X, Gong Q, Levine A, DelBello MP, Sweeny JA, Strawn JR. Greater Dynamic and Lower Static Functional Brain Connectivity Prospectively Predict Placebo Response in Pediatric Generalized Anxiety Disorder. Journal of Child & Adolescent Psychopharmacology. 2020;30(10):606-616. PMID: 32721213.
Mills JA and Strawn JR. Antidepressant tolerability in pediatric anxiety and obsessive-compulsive disorders: a Bayesian hierarchical modeling meta-analysis. Journal of the American Academy of Child & Adolescent Psychiatry. 2020;59(11):1240-1251. PMID: 31682918
Suresh V, Mills JA, Croarkin PE, Strawn JR. What next? A Bayesian hierarchical modeling re‐examination of treatments for adolescents with selective serotonin reuptake inhibitor‐resistant depression. Depression & Anxiety. 2020;37:926–934. PMID: 32579280
Strawn JR, Levine A. Treatment response biomarkers in anxiety disorders: from neuroimaging to neuronally-derived extracellular vesicles and beyond. Biomarkers in Neuropsychiatry. 2020;3:100024. PMCID: 7508464.
Strawn JR, Mills JA, Schroeder H, Mossman SA, Varney ST, Ramsey LB, Poweleit EA, Desta Z, Cecil K, DelBello MP. Escitalopram in adolescents with generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. Journal of Clinical Psychiatry. 2020;81(5):20m13396. PMID: 32857933
Sonmez AI, Almorsy AG, Ramsey LB, Strawn JR, Croarkin PE. Novel pharmacological treatments for generalized anxiety disorder: pediatric considerations. Depression & Anxiety. 2020;37(8):747-759. PMID: 32419335
Findling RL, McCusker E, Strawn JR. A randomized, double-blind, placebo-controlled trial of vilazodone in children and adolescents with major depressive disorder with twenty-six-week open-label follow-up. Journal of Child & Adolescent Psychopharmacology 2020; 2020;30(6):355-365. PMID: 32460523
Brown L, Eum S, Haga SB, Strawn JR, Zierhut H. Clinical utilization of pharmacogenetics in psychiatry - perspectives of pharmacists, genetic counselors, implementation science, clinicians, and industry. Pharmacopsychiatry. 2020;53(4):162-173. PMID: 31509860
Strawn JR, Walkup JT. Identifying the best treatment for young people with depression. Lancet Psychiatry 2020;7(7):562-563. PMID: 32563296
Walkup JT, Strawn JR. High-quality antidepressant prescribing: please consider whether “perfection is the enemy of progress.” BMC Medicine 2020;18(1):150. PMID: 32438910
Strawn JR, Elmaadawi AZ, Aaronsen ST, Schrodt GR, Holbert RC, Verdoliva S, Heart K, Croarkin PE. Treatment resistant depression in adolescents: clinical features and measurement of treatment resistance. Journal of Child & Adolescent Psychopharmacology. 2020;30(4):261-266. PMID: 32315537
Troy T*, Poweleit EA, Strawn JR, Martin LJ, Ramsey LB. The influence of pharmacodynamic genes on fluoxetine response in pediatric anxiety and depressive disorders. Journal of Child & Adolescent Psychopharmacology 2020;30(4):276-277. PMID: 32073889
Strawn JR, Croarkin PE. Treatment failure and success: a commentary on defining and treating pediatric treatment-resistant depression. Journal of Child Psychology and Psychiatry. 2020;61(3):333-335. PMID: 32034765
Huddart R, Hicks JK, Ramsey L, Strawn JR, Altman RB, Klein TE. PharmGKB summary: sertraline pathway, pharmacokinetics. Pharmacogenetics and Genomics 2020;30(2):26-33. PMID: 31851125.
Brokamp C, Strawn JR, Beck AF, Ryan P. Pediatric psychiatric emergency department utilization and fine particulate matter: a case-crossover study. Environmental Health Perspectives. 2019;127(9):097006-1-097006-7. PMID: 31553231
Ramsey LB, Bishop JR, Strawn JR. Pharmacogenetics of treating pediatric anxiety and depression. Pharmacogenomics 2019;20(12):867-870. PMID: 31453769
Luft MJ*, Aldrich SL, Poweleit E, Prows CA, Martin LJ, DelBello MP, Ramsey LB, Strawn JR. Thyroid function screening in children and adolescents with mood and anxiety disorders. Journal of Clinical Psychiatry. 2019;80(5):18m12626. PMID: 31390496
Nery FG, Weber WA, Blom TJ, Welge J, Patino LR, Strawn JR, Adler CM, Strakowski SM, DelBello MP. Longitudinal proton spectroscopy study of the prefrontal cortex in youth at risk for bipolar disorder before and after their first mood episode. Bipolar Disorders. 2019;21(4):330-341. PMID: 30864200
Poweleit E, Aldrich SL, Prows CA, Martin LJ, Strawn JR, Ramsey LB. CYP2C19 genotype and sertraline treatment response and tolerability in pediatric patients with depressive and anxiety disorders. Journal of Child & Adolescent Psychopharmacology. 2019; 29(5):348-361. PMID: 31066578
Strawn JR, Poweleit E, Ramsey LB. CYP2C19-guided escitalopram and sertraline dosing in pediatric patients: a pharmacokinetic modeling study. Journal of Child & Adolescent Psychopharmacology 2019; 29(5):340-347. PMID: 30817183
Strawn JR, Mills JF, Croarkin PE. Switching SSRIs in adolescents with SSRI-resistant major depressive disorder: balancing tolerability and efficacy Journal of Child & Adolescent Psychopharmacology. 2019;29(4):250-255. PMID: 30810350
Aldrich SL, Poweleit E, Prows CA, Martin LJ, Strawn JR, Ramsey LB. Influence of CYP2C19 metabolizer status on escitalopram/citalopram tolerability and response in youth with anxiety and depressive disorders. Frontiers in Pharmacology. 2019:10(99). PMID: 30837874
Dobson ET*, Bloch M, Strawn JR. Network meta-analysis: efficacy and tolerability of pharmacotherapy for pediatric anxiety disorders. Journal of Clinical Psychiatry. 2019;80(1):17r12064. PMID: 30753760
Strawn JR, Geracioti L, Rajdev N, Clemenza K, Levine A. Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review. Expert Opinion on Pharmacotherapy. 2018;19(10):1057-1070. PMID: 30056792
Haut SR, Lipton RB, Cornes S, Dwivedi AK, Wasson R, Cotton S, Strawn JR, Privitera M. Behavioral interventions as a treatment for epilepsy: a multicenter randomized controlled trial. Neurology. 2018; 90(11):e963-e970. PMID: 29444968
Strawn JR, Mills JA, Sauley B, Welge JA. The impact of antidepressant dose and class on treatment response in pediatric anxiety disorders: a meta-analysis. Journal of the American Academy of Child & Adolescent Psychiatry. 2018;57(4):235–244. PMID: 29588049
Luft MJ, Lamy M, DelBello MP, McNamara RK, Strawn JR. Antidepressant-induced activation in children and adolescents: risk, recognition and management. Current Problems in Pediatrics and Adolescent Health Care. 2018;48(2):50-62. PMID: 29358037
Wehry AM*, Ramsey L, Dulemba SE, Mossman SA, Strawn JR. Pharmacogenomic testing in child & adolescent psychiatry: an evidence-based review. Current Problems in Pediatrics and Adolescent Health Care. 2018;48(2):40-49. PMID: 29325731
Hathaway EE, Walkup JT, Strawn JR. Antidepressant treatment duration in pediatric depressive and anxiety disorders: how long is long enough? Current Problems in Pediatrics and Adolescent Health Care. 2018;48(2):31-39. PMID: 29337001
Strawn JR, Mills JA, Cornwall GJ, Mossman SA, Varney ST, Keeshin BR, Croarkin PE. Buspirone for the treatment of pediatric anxiety disorders: a review and Bayesian analysis of abandoned randomized controlled trials. Journal of Child & Adolescent Psychopharmacology. 2018;28(1):2-9. PMID: 28846022
Strawn JR, Vollmer LL, McMurray KMJ, Mills JA, Mossman SA, Varney ST, Schroeder HK, Sah R. Acid-sensing T cell death associated gene-8 receptor expression in panic disorder. Brain Behavior & Immunity. 2018;67:36-41. PMID: 28736033
Keeshin BR, Ding Q, Presson AP, Berkowitz SJ, Strawn JR. Use of prazosin for pediatric PTSD-associated nightmares and sleep disturbances: a retrospective chart review. Neurology and Therapy. 2017;6(2):247-257. PMID: 28755207
Strawn JR, Dobson ET*. Individuation for a DSM-5 disorder: adult separation anxiety. Depression & Anxiety. 2017;34:1082-1084. PMID: 29211944
Mossman SA, Luft MJ*, Schroeder HK, Varney ST, Fleck DE, Barzman DH, Gilman R, DelBello MP, Strawn JR. The Generalized Anxiety Disorder 7-item (GAD-7) scale in adolescents with generalized anxiety disorder: signal detection and validation. Annals of Clinical Psychiatry. 2017;29(4):227-234. PMID: 29069107
Strawn JR, Dobson ET*, Mills JA, Cornwall GJ, Sakolsky D, Birmaher B, Compton SN, Piacentini J, McCracken JT, Ginsburg GS, Kendall PC, Walkup JT, Albano AM, Rynn MA. Placebo response in pediatric anxiety disorders: results from the Child/Adolescent Anxiety Multimodal Study (CAMS). Journal of Child and Adolescent Psychopharmacology. 2017;27(6):501-508. PMID: 28384010
Strawn JR, Compton S, Robertson B, McMorn A, Hamdani M, Rynn MA. Extended-release guanfacine in pediatric anxiety disorders: a pilot, randomized, placebo-controlled trial. Journal of Child & Adolescent Psychopharmacology. 2017;27(1):29-37. PMID: 28165762
Tulisiak AK*, Klein JA, Harris E, Luft MJ*, Schroeder HK, Mossman SA, Varney ST, Keeshin BR, Cotton S, Strawn JR. Antidepressant prescribing by pediatricians: a mixed-methods analysis. Current Problems in Child & Adolescent Healthcare. 2017;S1538-5442(16):30106-7. PMID: 28057447
Strawn JR, Dobson ET* Giles LL. Primary pediatric care psychopharmacology: focus on medications for ADHD, depression and anxiety. Current Problems in Child & Adolescent Healthcare. 2017;S1538-5442(16)30105-5. PMID: 28043839
Welge JA, Saliba LJ, Strawn JR, Eliassen JC, Patino LR, Adler CM, Weber W, Schneider MR, Barzman DH, Strakowski SM, DelBello MP, McNamara RK. Neurofunctional differences among youth with and at varying risk for developing mania. Journal of the American Academy of Child & Adolescent Psychiatry. 2016;55(11):980–989. PMID: 27806866
Dobson ET*, Strawn JR. Placebo response in pediatric anxiety disorders: implications for clinical trials design and interpretation. Journal of Child & Adolescent Psychopharmacology. 2016;26(8):686-693. PMID: 27027330
McNamara RK, Jandacek R, Rider T, Tso P, Chu W-J, Weber WA, Welge JA, Strawn JR, Adler CM, DelBello MP. Effects of fish oil supplementation on prefrontal metabolite concentrations in adolescents with major depressive disorder: A preliminary 1H MRS study. Nutritional Neuroscience. 2016;19(4):145-55. PMID: 24915543
O’Malley J, Richer EJ, Strawn JR. Neuroimaging in children and adolescents: when do you scan? With which modalities? Current Psychiatry. 2016;15(9):33-54.
Hussain FS*, Dobson ET*, Strawn JR. Pharmacologic treatment of pediatric anxiety disorders. Current Treatment Options in Psychiatry. 2016;3(2):151-160. PMID: 27648401
Minton T*, Rosing J, Spar DS, Strawn JR, Garcia-Delgar B, Coffey BJ. Psychopharmacologic management of anxiety in an adolescent with congenital long QT syndrome. Journal of Child & Adolescent Psychopharmacology. 2016;26(5):485-489. PMID: 27285068
Strawn JR, Cotton S, Luberto CM, Patino LR, Stahl LA, Weber WA, Eliassen JC, Sears R, DelBello MP. Neural function before and after mindfulness-based cognitive therapy in anxious adolescents at risk for developing bipolar disorder. Journal of Child & Adolescent Psychopharmacology. 2016;26(4):372-377. PMID: 26783833
Melton TH, Croarkin PE, Strawn JR, McClintock SM. Comorbid anxiety and depressive symptoms in children and adolescents: a systematic review and analysis. Journal of Psychiatric Practice. 2016;22:84-98. PMID: 27138077
Dobson ET*, Strawn JR. Pharmacotherapy for pediatric generalized anxiety disorder: a systematic evaluation of efficacy, safety and tolerability. Paediatr Drugs. 2016;18(1):45-53. PMID: 26660158
Vollmer L, Strawn JR, Sah R. Acid-base dysregulation and chemosensory mechanisms in panic disorder: a translational update. Translational Psychiatry 5:e572. PMID: 26080089
Wehry AM*, Beesdo-Baum K, Hennely MM, Connolly SD, Strawn JR. Assessment and treatment of anxiety disorders in children and adolescents. Current Psychiatry Reports. 2015;17(7):591. PMID: 25980507
Strawn JR, Hamm L, Fitzgerald DA, Fitzgerald KD, Monk CS, Phan KL. Neurostructural abnormalities in pediatric anxiety disorders. Journal of Anxiety Disorders. 2015;32:81–88. PMID: 25890287
Strawn JR, Prakash A, Zhang Q, Pangallo BA, Stroud CE, Cai N, Findling RL. A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 2015;54(4):283-293. PMID: 25791145
Strawn JR, Welge JA, Wehry AM*, Keeshin B, Rynn MA. Antidepressant efficacy and tolerability in pediatric anxiety disorders: a systematic review and meta-analysis. Depression & Anxiety. 2015;32:149–157. PMID: 25449861
Wehry AM*, McNamara RK, Eliassen JC, Croarkin PE, Adler CM, DelBello MP, Strawn JR. Neurostructural impact of co-occurring anxiety in pediatric patients with major depressive disorder: a voxel-based morphometry study. Journal of Affective Disorders. 2015;171:54–59. PMID: 25285899
Strawn JR, Wegman CJ*, Dominick KC*, Schwartz MS*, Wehry AM*, Patino LR, Strakowski SM, Adler CM, Eliassen JC, DelBello MP. Cortical surface anatomy in pediatric patients with generalized anxiety disorder. Journal of Anxiety Disorders. 2014;28:717–723. PMID: 25155256
Strawn JR, Dominick KC*, Patino LR, Doyle CD*, Picard LS, Phan KL. Neurobiology of pediatric anxiety disorders. Current Behavioral Neuroscience Reports. 2014;1(3):154-160. PMID: 25745592
Alaka KJ, Noble W, Montejo A, Duéñas H, Munshi A, Strawn JR, Lenox-Smith A, Ahl J, Bidzan L, Dorn B, Ball S. Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial. International Journal of Geriatric Psychiatry. 2014;29(9):978-986. PMID: 24644106
Strawn JR, Wehry AM*, Chu WJ, Adler CM, Eliassen JC, Cerullo MA, Strakowski SM, Delbello MP. Neuroanatomic abnormalities in adolescents with generalized anxiety disorder: a voxel-based morphometry study. Depression & Anxiety. 2013;30(9):842-848. PMID: 23495075
Strawn JR, Chu W-J, Whitsel RM, Weber WA, Norris MM, Adler CM, Eliassen J, Phan KL Strakowski SM, DelBello MP. A pilot study of anterior cingulate cortex neurochemistry in adolescents with generalized anxiety disorder. Neuropsychobiology. 2013;67:224-229. PMID: 23635944
McNamara RK, Strawn JR. Role of long-chain omega-3 fatty acids in psychiatric practice. PharmaNutrition. 2013;1(2):41-49. PMID: 23607087
Strawn JR, Saldaña SN. Treatment with adjunctive N-acetylcysteine in an adolescent with selective serotonin reuptake inhibitor-resistant anxiety. Journal of Child and Adolescent Psychopharmacology. 2012;22(6):472-473. PMID: 23234593
Strawn JR, Bitter SM, Adler CM, Chu W, Eliassen JC, Whitsel R, Weber WA, Cerullo MA, Strakowski SM, DelBello MP. Neurocircuitry of generalized anxiety disorder in adolescents: a pilot functional magnetic resonance and functional connectivity study. Depression & Anxiety. 2012;29(11):939-47. PMID: 22628125
Strawn JR, Sakolsky DJ, Rynn MA. Psychopharmacologic treatment of anxiety disorders in children and adolescents. Child & Adolescent Psychiatric Clinics of North America. 2012;21(3):527-539. PMID: 22800992
Strawn JR, Wehry AM*, DelBello MP, Rynn MA, Strakowski SM. Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder. Depression & Anxiety. 2012;29:328-339. PMID: 22511364
Delgado SV, Strawn JR. Termination in psychodynamic psychotherapy with adolescents: a review and contemporary perspective. Bulletin of the Menninger Clinic. 2012;76(1):21-52. PMID: 22409205